Site-specific, sustained release of drugs to the brain N Bodor, HH Farag, ME Brewster III Science 214 (4527), 1370-1372, 1981 | 236 | 1981 |
A strategy for delivering peptides into the central nervous system by sequential metabolism N Bodor, L Prokai, WM Wu, H Farag, S Jonalagadda, M Kawamura, ... Science 257 (5077), 1698-1700, 1992 | 174 | 1992 |
Synthesis of curcumin analogues as potential antioxidant, cancer chemopreventive agents KM Youssef, MA El‐Sherbeny, FS El‐Shafie, HA Farag, OA Al‐Deeb, ... Archiv der Pharmazie: An International Journal Pharmaceutical and Medicinal …, 2004 | 166 | 2004 |
Synthesis and investigation of anti-inflammatory activity and gastric ulcerogenicity of novel nitric oxide-donating pyrazoline derivatives ME Shoman, M Abdel-Aziz, OM Aly, HH Farag, MA Morsy European journal of medicinal chemistry 44 (7), 3068-3076, 2009 | 108 | 2009 |
Improved delivery through biological membranes. 13. Brain-specific delivery of dopamine with a dihydropyridine. dblharw. pyridinium salt type redox delivery system N Bodor, HH Farag Journal of Medicinal Chemistry 26 (4), 528-534, 1983 | 87 | 1983 |
Design, synthesis and biological investigation of certain pyrazole-3-carboxylic acid derivatives as novel carriers for nitric oxide ESMN Abdel-Hafez, GEDAA Abuo-Rahma, M Abdel-Aziz, MF Radwan, ... Bioorganic & medicinal chemistry 17 (11), 3829-3837, 2009 | 82 | 2009 |
Microwave assisted synthesis of triazoloquinazolinones and benzimidazoquinazolinones AFE Mourad, AA Aly, HH Farag, EA Beshr Beilstein Journal of Organic Chemistry 3 (1), 11, 2007 | 81 | 2007 |
Reactivity of biologically important reduced pyridines. IV. Effect of substitution on ferricyanide-mediated oxidation rates of various 1, 4-dihydropyridines ME Brewster, A Simay, K Czako, D Winwood, H Farag, N Bodor The Journal of Organic Chemistry 54 (15), 3721-3726, 1989 | 78 | 1989 |
Improved delivery through biological membranes. 11. A redox chemical drug-delivery system and its use for brain-specific delivery of phenylethylamine N Bodor, HH Farag Journal of Medicinal Chemistry 26 (3), 313-318, 1983 | 75 | 1983 |
A redox chemical drug-delivery system and its use for brain-Tecif ic delivery of phenethylamine N Bodor, HH Farag J. Med. Chem 26, 313-318, 1983 | 64 | 1983 |
Improved delivery through biological membranes XIV: Brain‐specific, sustained delivery of testosterone using a redox chemical delivery system N Bodor, HH Farag Journal of pharmaceutical sciences 73 (3), 385-389, 1984 | 59 | 1984 |
Receptor binding studies of soft anticholinergic agents F Huang, P Buchwald, CE Browne, HH Farag, WM Wu, F Ji, G Hochhaus, ... AAPS PharmSci 3, 44-56, 2001 | 45 | 2001 |
Chlorzoxazone esters of some non-steroidal anti-inflammatory (NSAI) carboxylic acids as mutual prodrugs: design, synthesis, pharmacological investigations and docking studies AZ Abdel-Azeem, AA Abdel-Hafez, GS El-Karamany, HH Farag Bioorganic & medicinal chemistry 17 (10), 3665-3670, 2009 | 42 | 2009 |
Synthesis, anti-inflammatory activity and ulcerogenic liability of novel nitric oxide donating/chalcone hybrids GEDAA Abuo-Rahma, M Abdel-Aziz, MAE Mourad, HH Farag Bioorganic & medicinal chemistry 20 (1), 195-206, 2012 | 40 | 2012 |
Imidazo {2, 1-b] benzothiazoles. II.: Synthesis and Antinflammatory Activity of Some Imidazo [2, 1-b] benzothiazoles AN EL-SHORBAGI, S SAKAI, MA EL-GENDY, N OMAR, HH FARAG Chemical and pharmaceutical bulletin 37 (11), 2971-2975, 1989 | 40 | 1989 |
Design and synthesis of novel isatin-based derivatives targeting cell cycle checkpoint pathways as potential anticancer agents MA Yousef, AM Ali, WM El-Sayed, WS Qayed, HHA Farag, T Aboul-Fadl Bioorganic chemistry 105, 104366, 2020 | 32 | 2020 |
1, 2‐dihydroisoquinoline‐N‐acetic acid derivatives as new carriers for specific brain delivery I: synthesis and estimation of oxidation kinetics using multivariate calibration … S Mahmoud, T Aboul‐Fadl, M Sheha, H Farag, AMI Mouhamed Archiv der Pharmazie: An International Journal Pharmaceutical and Medicinal …, 2003 | 31 | 2003 |
Desorption chemical ionization, thermospray, and fast atom bombardment mass spectrometry of dihydropyridine. dblharw. pyridinium salt-type redox systems L Prokai, BH Hsu, H Farag, N Bodor Analytical chemistry 61 (15), 1723-1728, 1989 | 31 | 1989 |
Brain delivery of HIV protease inhibitors MM Sheha, NA El‐Koussi, HH Farag Archiv der Pharmazie: An International Journal Pharmaceutical and Medicinal …, 2003 | 30 | 2003 |
1-Malonyl-1, 4-dihydropyridine as a novel carrier for specific delivery of drugs to the brain HA Hassan, M Abdel-Aziz, GEDAA Abuo-Rahma, HH Farag Bioorganic & Medicinal Chemistry 17 (4), 1681-1692, 2009 | 29 | 2009 |